ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of May 19, 2026, CLPT trades at $11.15 with a market cap of $349.08M and a P/E ratio of -15.82. CLPT moved -4.55% today. Year to date, CLPT is -20.67%; over the trailing twelve months it is -15.55%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ClearPoint Neuro, Inc. Common Stock (CLPT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CLPT moved -4.55% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $11.15 |
| Market Cap | $349.08M |
| P/E Ratio | -15.82 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.10 |
| 52-Week Low | $8.27 |
| Volume | 30 |
| Avg Volume | 0 |
| Revenue (TTM) | $31.39M |
| Net Income | $-18.91M |
| Gross Margin | 60.92% |
3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.